Related Experiment Video
Updated: May 22, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
MASP interactions with plasma-derived MBL
Inga A Laursen1, Nicole M Thielens, Michael Christiansen
1CEA, DSV, Institut de Biologie Structurale (IBS), Grenoble F-38027, France. nicole.thielens@ibs.fr
Abstract:
The interaction of mannan-binding lectin (MBL) with its associated serine proteases (MASPs) was investigated using recombinant (r) MBL, plasma-derived (pd) MBL, rMASP-3 and rMAp19. When mixed with MBL-deficient serum, rMBL and pdMBL associated with free MASP-2 to (re)gain complement-activating activity. MASPs already associated with pdMBL did not exchange with rMASP-3 or rMAp19, which bound to non-overlapping sites on MBL. Thus, rMASP-3 and rMAp19 bound to free available sites on rMBL and pdMBL. These results have important implications for the therapeutic use of MBL preparations.
Insights
Recombinant and plasma-derived mannan-binding lectin (MBL) regained complement activity by binding free MASP-2. New serine proteases (MASP-3, MAp19) bound to separate MBL sites, impacting MBL therapeutics.
Area of Science:
- Immunology
- Complement System
- Protein Interactions
Background:
- Mannan-binding lectin (MBL) is a key initiator of the lectin pathway of complement.
- MBL functions by associating with MBL-associated serine proteases (MASPs).
- Understanding MBL-MASP interactions is crucial for modulating complement activity.
Purpose of the Study:
- To investigate the binding interactions between recombinant (r) MBL, plasma-derived (pd) MBL, and MASPs.
- To determine how recombinant MASP-3 (rMASP-3) and recombinant MAp19 (rMAp19) interact with MBL.
- To assess the functional consequences of these interactions on complement activation.
Main Methods:
- Utilized recombinant MBL (rMBL) and plasma-derived MBL (pdMBL).
- Employed recombinant MASP-3 (rMASP-3) and recombinant MAp19 (rMAp19).
- Assessed complement-activating activity in MBL-deficient serum.
Main Results:
- Recombinant MBL and plasma-derived MBL associated with free MASP-2, restoring complement-activating function.
- MASPs pre-associated with plasma-derived MBL did not exchange with rMASP-3 or rMAp19.
- rMASP-3 and rMAp19 bound to distinct, non-overlapping sites on both rMBL and pdMBL.
Conclusions:
- The binding of MASPs to MBL is specific and site-dependent.
- Recombinant MASP-3 and MAp19 can bind MBL independently of existing MASP complexes.
- These findings have significant implications for the development and therapeutic application of MBL-based strategies.
Related Concept Videos
MALDI-TOF Mass Spectrometry
Matrix-Assisted Laser Desorption Ionization (MALDI)
Clinical Significance of Antibiotic Resistance

